Table 2.
Vaccine formulations using Hepatitis B surface antigen (HBsAg) as antigen.
| Group No. (n = 5) | Adjuvant | Adjuvant Dose µg/50 µL |
|---|---|---|
| 1 | None (HBsAg alone) | - |
| 2 | SLA | 1000 |
| 3 | Poly(I:C) | 40 |
| 4 | SLA + Poly(I:C) | 1000 + 40 |
| 5 | CpG | 10 |
| 6 | SLA + CpG | 1000 + 10 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.